WFA Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50
Closed -$3.94K 208
2025
Q2
$3.94K Hold
50
﹤0.01% 181
2025
Q1
$4.36K Buy
+50
New +$4.47K ﹤0.01% 202
2024
Q3
Sell
-50
Closed -$3.94K 209
2024
Q2
$3.94K Hold
50
﹤0.01% 182
2024
Q1
$4.36K Sell
50
-200
-80% -$17.1K ﹤0.01% 203
2023
Q4
$20.6K Sell
250
-65
-21% -$4.95K 0.01% 142
2023
Q3
$24.7K Buy
315
+15
+5% +$1.26K 0.01% 135
2023
Q2
$26.4K Hold
300
0.02% 133
2023
Q1
$24.2K Buy
+300
New +$24.5K 0.01% 135

Other funds holding MDT

WFA Asset Management's MDT Position: Q3 2025 in Review

WFA Asset Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 50 shares — an estimated $3.94K sold.

WFA Asset Management first reported a position in MDT in Q1 2023 and held it in 8 quarters. The position peaked at $26.4K in Q2 2023. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • WFA Asset Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • WFA Asset Management sold 50 Medtronic shares in Q3 2025, an estimated $3.94K.
  • WFA Asset Management first reported a position in Medtronic in Q1 2023 and held it in 8 quarters.
  • WFA Asset Management's Medtronic position peaked at $26.4K in Q2 2023.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.